The Long Term Effects of COVID on Pulmonary Function

Overview

An observational cohort study of patients discharged from the ICU following admission with COVID19 infection, looking at their medical wellbeing 6 months after discharge from the ICU.

Full Title of Study: “Long Term Outcomes of COVID-19 Critical Illness: Cohort Study of Adult Patients Admitted to the Intensive Care Unit at Mater Dei Hospital With COVID-19 Infection”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: December 31, 2021

Detailed Description

The COVID-19 epidemic has placed an unprecedented strain on medical services worldwide. Throughout 2020 and early 2021, hospitals and their critical care services have been inundated with patients suffering from critical illness due to COVID-19, some of whom developed multi-organ failure and required a prolonged ICU stay. While the medical literature is now replete with publications and research on the acute phase of illness due to COVID-19, including critical illness, there is a paucity of studies detailing the long-term outcomes following COVID-19 critical illness. While the negative long-term physical health, mental health and quality-of-life related effects of ARDS have been well documented, there has been very little long-term COVID-19 ARDS specific outcome studies published. This is an observational cohort study that aims to assess the long-term health outcomes of adult patients admitted to Mater Dei Hospital Intensive Care Unit with COVID-19 infection. Patients will initially be assessed at 6 months after discharge from ITU. They will be interviewed by trained researchers using validated questionnaires. These questionnaires will assess their physical health, mental health and functional status. Participants will be examined and asked to do a 6minute walk test also using validated non-invasive physical assessment tools. They will be offered pulmonary function tests to be carried out at the Pulmonary function laboratory.

Interventions

  • Diagnostic Test: Spirometry
    • Spirometry to assess lung function
  • Diagnostic Test: 6-minute walk
    • Exercise tolerance

Clinical Trial Outcome Measures

Primary Measures

  • Long term general health effects of critical illness due to COVID-19 infection
    • Time Frame: at 6 months
    • Observation of the effect critical illness due to COVID-19 has on a patients’ health related quality of life at 6 and 12 months after discharge from the ICU
  • Long term general health effects of critical illness due to COVID-19 infection
    • Time Frame: at 12 months
    • Observation of the effect critical illness due to COVID-19 has on a patients’ health related quality of life at 6 and 12 months after discharge from the ICU

Secondary Measures

  • Correlation between severity of COVID19 illness and QOL
    • Time Frame: at 6 months
    • Observation of how different severity of critical illness secondary to COVID-19 infection correlates with medium and long-term health related quality of life outcomes.
  • Correlation between severity of COVID19 illness and QOL
    • Time Frame: at 12 months
    • Observation of how different severity of critical illness secondary to COVID-19 infection correlates with medium and long-term health related quality of life outcomes.

Participating in This Clinical Trial

Inclusion Criteria

  • All patients admitted to the Intensive Care Unit with organ failure secondary to acute COVID-19 infection and successfully discharged from Mater Dei Hospital and surviving beyond 6 months after discharge, will be offered inclusion in the study. A positive COVID PCR result before or during the patient's admission will be necessary for inclusion in the study. Participants will be over 18 years of age, with no restriction as regards race, ethnicity or gender. Exclusion Criteria:

  • There are no exclusion criteria

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 95 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Sciberras, Stephen M.D.
  • Collaborator
    • Mater Dei Hospital, Malta
  • Provider of Information About this Clinical Study
    • Principal Investigator: Stephen Sciberras, Supervisor – Sciberras, Stephen M.D.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.